Anticancer Therapies – Multimedia

2019 has been an exciting year for the cancer research field. This list details the top 10 most-read news stories from the field this year, published on Technology Networks.

This listicle explores the five different types of immunotherapy, how each type works, and takes a closer look at some examples of approved immunotherapies.

Download this handbook to advance your understanding of how cell culture models can drive breakthroughs in these areas of cancer research.

In a talk about a breakthrough, CAR T-cell therapy pioneer, Carl June shares how three decades of research culminated in a therapy that's eradicated cases of leukemia once thought to be incurable – and explains how it could be used to fight other types of cancer.

Researchers are developing third generation CAR-T immunotherapy treatments which aim to be more effective with less side effects than previous therapies.

Find out about why there is so much excitement about this new therapy, which patients are the best candidates, as well as CAR T-cell effectiveness, safety, and costs.

Traditionally, cancer treatment has revolved around chemotherapy, radiation and surgery. But thanks to groundbreaking immune checkpoint blockade research led by Jim Allison, Ph.D., winner of the 2018 Nobel Prize in Physiology or Medicine, we have a new way to treat cancer: immunotherapy. Rather than treating the cancer directly, immunotherapy trains the immune system to attack cancer.

Nanoparticles are capable of carrying chemotherapy to areas of the body afflicted by cancer. However, what if these nanoparticles were specifically targeted to treat only cancer cells and not healthy cells?

Tremendous progress has been made in the cancer research field over the past 20 years. This infographic highlights 10 major milestones since the year 2000.

This list highlights ten major milestones within the field of cancer research since the year 2000.